Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia

American Journal of Psychiatry

Volumn 162, Issue 5, 2005, Pages 931-938

  Lehrer, Douglas S ^a,b   Christian, Bradley T ^a   Mantil, Joseph ^a   Murray, Aaron C ^a   Buchsbaum, Bradley R ^a   Oakes, Terrence R ^a   Byne, William ^a   Kemether, Eileen M ^a   Buchsbaum, Monte S ^a  

^a Wallace Kettering Neuroscience Institute   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY SYSTEM; TASK PERFORMANCE; THALAMUS; THALAMUS POSTERIOR NUCLEUS;

ADULT; ATTENTION; CORPUS STRIATUM; FEMALE; FLUORODEOXYGLUCOSE F18; FORM PERCEPTION; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; PULVINAR; SCHIZOPHRENIA; TASK PERFORMANCE AND ANALYSIS; THALAMUS;

EID: 18744376065     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.5.931     Document Type: Article

References (47)

1. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001; 49:1-52
2. Buchsbaum M, Hazlett E: Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998; 24:343-364
3. Jones E: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483-501
4. Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, Siever LJ: Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry 2001; 58:133-140
5. Kemether EM, Buchsbaum MS, Byne W, Hazlett EA, Haznedar M, Brickman AM, Platholi J, Bloom R: Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry 2003; 60:983-991
6. Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr: PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996; 153:191-199
7. Buchsbaum M, Ingvar D, Kessler R, Waters R, Cappelletti J, van Kammen D, King A, Johnson J, Manning R, Flynn R, Mann L, Bunney WJ, Sokoloff L: Cerebral glucography with positron tomography. Arch Gen Psychiatry 1982; 39:251-259
8. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, Wu J: Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 79 unmedicated male schizophrenics. Am J Psychiatry 1993; 150:1325-1336
9. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD: Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997; 349:1730-1734
10. Hazlett EA, Buchsbaum MS, Byne W, Wei T-C, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar MM, Shihabuddin L, Siever LJ: Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156:1190-1199
11. Hazlett EA, Buchsbaum MS, Kemether E, Bloom R, Platholi J, Brickman AM, Shihabuddin L, Tang C, Byne W: Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry 2004; 161:305-314
12. LaBerge D, Buchsbaum MS: Positron emission tomographic measurements of pulvinar activity during an attention task. J Neurosci 1990; 10:613-619
13. Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615-623
14. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
15. Kane JM, Schooler NR: Tardive Dyskinesia Workgroup report. Psychopharmacol Bull 1980; 16:35-36
16. Hollingshead AB, Redlich FC: Social Class and Mental Illness: A Community Study. New York, John Wiley & Sons, 1958
17. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ: Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38:1614-1623
18. Fristen K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak R: Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2:189-210
19. Smith SM: Fast robust automated brain extraction. Hum Brain Mapp 2002; 17:143-155
20. Jenkinson M, Smith S: A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143-156
21. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH: An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19:1233-1239
22. Devinsky O, Morrell M, Vogt B: Contributions of anterior cingulate cortex to behavior. Brain 1995; 118:279-306
23. Sossi V: Correction for image degrading factors is essential for accurate quantification of brain function using PET: against the proposition. Med Phys 2004; 31:425-426
24. Zaidi H. Correction for image degrading factors is essential for accurate quantification of brain function using PET: for the proposition. Med Phys 2004; 31:423-425
25. Buchsbaum MS, Hazlett EA, Haznedar MM, Spiegel-Cohen J, Wei TC: Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia. Acta Psychiatr Scand Suppl 1999; 395: 129-137
26. Lacerda AL, Dalgalarrondo P, Caetano D, Camargo EE, Etchebehere EC, Soares JC: Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res 2003; 123:125-134
27. Potkin SG, Buchsbaum MS, Jin Y, Tang C, Telford J, Friedman G, Lottenberg S, Najafi A, Gulasekaram B, Costa J, et al.: Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry 1994; 55(suppl B):63-66
28. Desco M, Gispert JD, Reig S, Sanz J, Pascau J, Sarramea F, Benito C, Santos A, Palomo T, Molina V: Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res 2003; 122:125-135
29. Molina V, Gispert J D, Reig S, Sanz J, Pascau J, Santos A, Palomo T, Desco M: Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr Res 2003; 60:1-7
30. Molina V, Reig S, Pascau J, Sanz J, Sarramea F, Gispert JD, Luque R, Benito C, Palomo T, Desco M: Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia. Psychiatry Res 2003; 124:163-175
31. Paradiso S, Andreasen NC, Crespo-Facorro B, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD: Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry 2003; 160:1775-1783
32. Clark C, Kopala L, Li DK, Hurwitz T: Regional cerebral glucose metabolism in never-medicated patients with schizophrenia. Can J Psychiatry 2001; 46:340-345
33. Volz H, Gaser C, Hager F, Rzanny R, Ponisch J, Mentzel H, Kaiser WA, Sauer H: Decreased frontal activation in schizophrenics during stimulation with the Continuous Performance Test-a functional magnetic resonance imaging study. Eur Psychiatry 1999; 14:17-24
34. Kumari V, Gray JA, Geyer MA, ffytche D, Soni W, Mitterschiffthaler MT, Vythelingum GN, Simmons A, Williams SC, Sharma T: Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 2003; 122:99-113
35. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL: Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000; 48:99-109
36. Giguere M, Goldman-Rakic PS: Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol 1988; 277:195-213
37. Rose J, Woolsey C: The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep, and cat. Assoc Res Nerv Ment Dis Proc 1948; 27:210-282
38. Crosson B: Subcortical mechanisms in language: lexical-semantic mechanisms and the thalamus. Brain Cogn 1999; 40: 414-438
39. Strungas S, Christensen JD, Holcomb JM, Garver DL: State-related thalamic changes during antipsychotic treatment in schizophrenia: preliminary observations. Psychiatry Res 2003; 124:121-124
40. Talvik M, Nordstrom AL, Olsson H, Halldin C, Farde L: Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457. Int J Neuropsychopharmacol 2003; 6:361-370
41. Goldman-Rakic PS, Porrino LJ: The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985; 242:535-560
42. Romanski LM, Giguere M, Bates JF, Goldman-Rakic PS: Topographic organization of medial pulvinar connections with the prefrontal cortex in the rhesus monkey. J Comp Neurol 1997; 379:313-332
43. Grieve KL, Acuna C, Cudeiro J: The primate pulvinar nuclei: vision and action. Trends Neurosci 2000; 23:35-39
44. Robinson DL: Functional contributions of the primate pulvinar. Prog Brain Res 1993; 95:371-380
45. Wester K, Irvine DR, Hugdahl K: Auditory laterality and attentional deficits after thalamic haemorrhage. J Neurol 2001; 248: 676-683
46. Benevento LA, Port JD: Single neurons with both form/color differential responses and saccade-related responses in the nonretinotopic pulvinar of the behaving macaque monkey. Vis Neurosci 1995; 12:523-544
47. Kapur S: Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160:13-23